Literature DB >> 14978024

Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice.

Judith Branger1, Jaklien C Leemans, Sandrine Florquin, Sebastiaan Weijer, Peter Speelman, Tom Van Der Poll.   

Abstract

Toll-like receptors (TLR) play an essential role in the innate recognition of microorganisms by the host. To determine the role of TLR4 in host defense against lung tuberculosis, TLR4 mutant (C3H/HeJ) and wild-type (C3H/HeN) mice were intranasally infected with live Mycobacterium tuberculosis. TLR4 mutant mice were more susceptible to pulmonary tuberculosis, as indicated by a reduced survival and an enhanced mycobacterial outgrowth. Lung infiltrates were more profound in TLR4 mutant mice and contained more activated T cells. Splenocytes of infected TLR4 mutant mice demonstrated a reduced capacity to produce the protective type 1 cytokine IFN-gamma upon antigen-specific stimulation, indicating that TLR4 may be involved in the generation of acquired T cell-mediated immunity. These data suggest that TLR4 plays a protective role in host defense against lung infection by M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978024     DOI: 10.1093/intimm/dxh052

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  30 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

Review 2.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

3.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

Review 4.  Role of CD14 in lung inflammation and infection.

Authors:  Adam Anas; Tom van der Poll; Alex F de Vos
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

5.  CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis.

Authors:  Catharina W Wieland; Gerritje J W van der Windt; W Joost Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2008-04-03       Impact factor: 7.397

6.  The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.

Authors:  Jiazhu Fang; Dan Fang; Phyllis B Silver; Feng Wen; Bing Li; Xiangrong Ren; Qing Lin; Rachel R Caspi; Shao Bo Su
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

Review 7.  The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis.

Authors:  Jialu Ma; Shasha Zhao; Xiao Gao; Rui Wang; Juan Liu; Xiangmei Zhou; Yang Zhou
Journal:  Pathogens       Date:  2021-01-25

8.  Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.

Authors:  Wagner J Fávaro; Odilon S Nunes; Fabio Rf Seiva; Iseu S Nunes; Lisa K Woolhiser; Nelson Durán; Anne J Lenaerts
Journal:  Infect Agent Cancer       Date:  2012-06-18       Impact factor: 2.965

9.  An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins.

Authors:  Rahul Sharma; Vikrant Singh Rajput; Salma Jamal; Abhinav Grover; Sonam Grover
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.